In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamases
- 31 August 2001
- journal article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 40 (4), 173-177
- https://doi.org/10.1016/s0732-8893(01)00269-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Worldwide Prevalence of Antimicrobial Resistance inStreptococcus pneumoniae, Haemophilus influenzae,andMoraxella catarrhalisin the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 2000
- In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)Antimicrobial Agents and Chemotherapy, 1999
- Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO antimicrobial activity studied against gram-positive speciesDiagnostic Microbiology and Infectious Disease, 1996
- In-vitro activity of two glycylcyclines against enterococci resistant to other agentsJournal of Antimicrobial Chemotherapy, 1995
- Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclinesAntimicrobial Agents and Chemotherapy, 1994
- N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocciAntimicrobial Agents and Chemotherapy, 1994
- In vitro activities of two glycylcyclines against gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1994
- In vitro activity of DMG-mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993